SKK
ISEE

Shepherd Kaplan Krochuk’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,111
Closed -$284K – 458
2015
Q1 		$284K Sell
6,111
-10,622
-63% -$551K 0.05% 246
2014
Q4 		$751K Hold
16,733
– – 0.12% 155
2014
Q3 		$651K Buy
16,733
+1,810
+12% +$71K 0.08% 174
2014
Q2 		$631K Buy
14,923
+5,532
+59% +$203K 0.07% 186
2014
Q1 		$335K Buy
+9,391
New +$317K 0.04% 283

Other funds holding ISEE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Shepherd Kaplan Krochuk's ISEE Position: Q2 2015 in Review

Shepherd Kaplan Krochuk sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2015, closing a stake of 6,111 shares — an estimated $284K sold.

Shepherd Kaplan Krochuk first reported a position in ISEE in Q1 2014 and held it in 5 quarters. The position peaked at $751K in Q4 2014. 139 funds tracked by Wall St. Rank hold ISEE as of Q2 2015.

  • Shepherd Kaplan Krochuk reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 6,111 IVERIC bio, Inc. Common Stock shares in Q2 2015, an estimated $284K.
  • Shepherd Kaplan Krochuk first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 5 quarters.
  • Shepherd Kaplan Krochuk's IVERIC bio, Inc. Common Stock position peaked at $751K in Q4 2014.
  • 139 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2015, filed 14 Aug 2015.